These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23571175)

  • 21. Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso.
    Bonkoungou IJO; Aliabadi N; Leshem E; Kam M; Nezien D; Drabo MK; Nikiema M; Ouedraogo B; Medah I; Konaté S; Ouédraogo-Traoré R; Sangaré L; Kam L; Yé D; Ouattara M; Biey JN; Mwenda JM; Tate JE; Parashar UD
    Vaccine; 2018 Nov; 36(47):7170-7178. PubMed ID: 29290478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of rotavirus vaccines in an Australian population: A case-control study.
    Fathima P; Snelling TL; Gibbs RA
    Vaccine; 2019 Sep; 37(41):6048-6053. PubMed ID: 31473003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospital-based surveillance and analysis of genotype variation in Nicaragua after the introduction of the pentavalent rotavirus vaccine.
    Khawaja S; Cardellino A; Mast TC
    Pediatr Infect Dis J; 2014 Jan; 33(1):e25-8. PubMed ID: 24042492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia.
    Field EJ; Vally H; Grimwood K; Lambert SB
    Pediatrics; 2010 Sep; 126(3):e506-12. PubMed ID: 20732946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala.
    Gastañaduy PA; Contreras-Roldán I; Bernart C; López B; Benoit SR; Xuya M; Muñoz F; Desai R; Quaye O; Tam KI; Evans-Bowen DK; Parashar UD; Patel M; McCracken JP
    Clin Infect Dis; 2016 May; 62 Suppl 2():S121-6. PubMed ID: 27059345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of childhood rotavirus vaccination in Germany.
    Aidelsburger P; Grabein K; Böhm K; Dietl M; Wasem J; Koch J; Ultsch B; Weidemann F; Wichmann O
    Vaccine; 2014 Apr; 32(17):1964-74. PubMed ID: 24561052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program.
    Amador JJ; Vasquez J; Orozco M; Pedreira C; Malespin O; De Oliveira LH; Tate J; Parashar U; Patel M
    Int J Infect Dis; 2010 Jul; 14(7):e592-5. PubMed ID: 20022778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.
    Doll MK; Buckeridge DL; Morrison KT; Gagneur A; Tapiero B; Charest H; Quach C
    Vaccine; 2015 Dec; 33(51):7307-7314. PubMed ID: 26546262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study.
    Fu C; Wang M; Liang J; He T; Wang D; Xu J
    Vaccine; 2007 Dec; 25(52):8756-61. PubMed ID: 18023510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.
    Payne DC; Staat MA; Edwards KM; Szilagyi PG; Gentsch JR; Stockman LJ; Curns AT; Griffin M; Weinberg GA; Hall CB; Fairbrother G; Alexander J; Parashar UD
    Pediatrics; 2008 Dec; 122(6):1235-43. PubMed ID: 19047240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana.
    Armah G; Pringle K; Enweronu-Laryea CC; Ansong D; Mwenda JM; Diamenu SK; Narh C; Lartey B; Binka F; Grytdal S; Patel M; Parashar U; Lopman B
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S200-7. PubMed ID: 27059357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses.
    Bar-Zeev N; Jere KC; Bennett A; Pollock L; Tate JE; Nakagomi O; Iturriza-Gomara M; Costello A; Mwansambo C; Parashar UD; Heyderman RS; French N; Cunliffe NA;
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S213-9. PubMed ID: 27059359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya.
    Feikin DR; Laserson KF; Ojwando J; Nyambane G; Ssempijja V; Audi A; Nyakundi D; Oyieko J; Dallas MJ; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A52-60. PubMed ID: 22520137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of rotavirus vaccines against hospitalisations in Japan.
    Fujii Y; Noguchi A; Miura S; Ishii H; Nakagomi T; Nakagomi O; Takahashi T
    BMC Pediatr; 2017 Jul; 17(1):156. PubMed ID: 28693503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the state immunization information system to assess rotavirus vaccine effectiveness in Connecticut, 2006-2008.
    Guh AY; Hadler JL
    Vaccine; 2011 Aug; 29(37):6155-8. PubMed ID: 21723356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitigating bias in observational vaccine effectiveness studies using simulated comparator populations: Application to rotavirus vaccination in the UK.
    Hungerford D; Vivancos R; Read JM; Bonnett LJ; Bar-Zeev N; Iturriza-Gómara M; Cunliffe NA; French N
    Vaccine; 2018 Oct; 36(45):6674-6682. PubMed ID: 30293764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhesus rotavirus vaccine effectiveness and factors associated with receipt of vaccine.
    Staat MA; Cortese MM; Bresee JS; Bégué RE; Vitek C; Rhodes P; Zhang R; Gentsch J; Roberts NE; Jaeger JL; Ward R; Bernstein DI; Dennehy PH
    Pediatr Infect Dis J; 2006 Nov; 25(11):1013-8. PubMed ID: 17072123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of rotavirus vaccination on an emerging G8P[8] rotavirus strain causing an outbreak in central Japan.
    Hoque SA; Kobayashi M; Takanashi S; Anwar KS; Watanabe T; Khamrin P; Okitsu S; Hayakawa S; Ushijima H
    Vaccine; 2018 Jan; 36(1):43-49. PubMed ID: 29183732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the health impact of a public-private partnership: to reduce rotavirus disease in Nicaragua.
    Khawaja S; Cardellino A; Klotz D; Kuter BJ; Feinberg MB; Colatrella BD; Mast TC
    Hum Vaccin Immunother; 2012 Jun; 8(6):777-82. PubMed ID: 22495114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants.
    Vesikari T; Prymula R; Schuster V; Tejedor JC; Cohen R; Bouckenooghe A; Damaso S; Han HH
    Pediatr Infect Dis J; 2012 May; 31(5):509-13. PubMed ID: 22228235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.